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Introduction: Osteoarthritis (OA) is characterized by an imbalance in cartilage and underlying subchondral bone
homeostasis. We hypothesized that signals from the subchondral bone may modulate production of matrix
components, alter chondrogenic differentiation potential of cocultured bone marrow-derived mesenchymal stem
cells (BMSC) and induce a phenotypic shift in differentiated OA chondrocytes.
Methods: We established a novel coculture model between BMSC, mixed cultures (BMSC and chondrocytes) and
chondrocytes embedded in fibrin gel with OA and normal subchondral bone explants (OAB and NB). Tissues and
cells were either derived from OA or trauma patients. In addition, we used adipose-derived stem cells (ASC) from
liposuction. With gene expression analysis, biochemical assays, immunofluorescence and biomechanical tests we
characterized the properties of newly generated extracellular matrix (ECM) from chondrocytes and chondrogenically
differentiating BMSC cocultured with OAB or NB in comparison with monocultures (cultures without bone explants).
Results: Overall, gene expression of collagens of OAB and NB cocultured cells was reduced compared to
monocultures. Concomitantly, we observed significantly lower collagen I, II and III and glycosaminoglycan (GAG)
production in OAB cocultured cell lysates. In parallel, we detected increased concentrations of soluble GAGs and basic
fibroblast growth factor (bFGF), interleukin (IL)-6 and IL-8 in supernatants of OAB and NB cocultures mainly at early time
points. IL-1ß concentration was increased in supernatants of OAB cocultures, but not in NB cocultures. Cell-free NB or
OAB explants released different amounts of IL-1ß, bFGF and soluble GAG into cell culture supernatants. In comparison
to cocultures, monocultures exhibited higher Young’s modulus and equilibrium modulus. Stimulation of monocultures
with IL-1ß led to a downregulation of aggrecan (ACAN) gene expression and in general to induced matrix metalloprotease
(MMP)2, MMP3 and MMP-13 gene expression while IL-6 and IL-8 stimulation partly reduced ACAN, MMP3 and
MMP-13 gene expression.
Conclusions: Our results suggest an alteration of molecular composition and mechanical properties of the newly
formed ECM in subchondral bone cocultures. We suggest that soluble factors, that is interleukins and bFGF,
released in cocultures exert inhibitory effects on collagen and temporary effects on proteoglycan production,
which finally results in a reduction of mechanical strength of newly formed fibrillar networks.* Correspondence: susanne.graessel@klinik.uni-regensburg.de
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For long-term repair and regeneration of focal cartilage
defects, chondrocytes are implanted at the site of injury,
however, not much attention has been paid to the micro-
environmental effects of neighboring cartilage/subchon-
dral bone. This is specifically evident in diseases affecting
diarthrodial joints such as osteoarthritis (OA), which is an
age-related and/or trauma-induced multifactorial, slowly
progressing and primarily noninflammatory degenerative
disorder of the synovial joints culminating in the irrevers-
ible destruction of the articular cartilage [1,2].
Research has focused on chondrocytes and cartilage as
mediators of OA but also other cells and tissues of the
joint-like synovium or subchondral bone are known to be
involved in OA-pathogenesis. There is strong evidence for
bone changes during OA progression: increased turnover
of subchondral bone, thinning trabecular structures, scler-
osis of the subchondral plate, bone marrow lesions and
subchondral bone cysts [3,4]. Other studies showed alter-
ations in the collagen turnover and cytokine release of
osteoarthritic subchondral bone matrix [5,6].
Therapies using adult bone marrow-derived mesenchy-
mal stem cells (BMSC) have a promising future to facili-
tate regenerative musculoskeletal tissue repair. Especially,
BMSC are identified as a relevant cell source for regener-
ation of focal cartilage and bone lesions, because they can
be readily expanded in vitro - whereas differentiated cells,
that is chondrocytes dedifferentiate upon expansion [7].
BMSC are pluripotent cells that inherit the capacity to dif-
ferentiate into cartilage, bone, fat, and other tissue types
after appropriate in vitro induction [8].
So far, OA-related cartilage lesions and fissures have
not been a widely clinically approved target for BMSC-
based therapies as this would imply to implant cells into
the neighborhood of diseased tissue where they are con-
fronted with an altered microenvironment of the neigh-
boring pathological cartilage and subchondral bone tissue.
It has been demonstrated that BMSC are able to differen-
tiate into a specific cell phenotype depending on the envir-
onment they are actually residing in. Crosstalk between
BMSC and extracellular matrix (ECM) components could
be a crucial determining factor for the differentiation of
BMSC into chondrocytes [9]. Indeed, the microenviron-
ment of OA subchondral bone (OAB) is likely to have an
influence on the ability of BMSC to regenerate articular
cartilage or subchondral bone matrix as implanted stem
cells may respond in a different way to differentiation
stimuli due to signaling factors secreted from neighboring
OA chondrocytes or osteoblasts [10].
One way to direct and redirect the differentiation of
BMSC are coculture systems that promote diffusion
of secreted paracrine factors and cell-cell interactions
[11,12]. Westacott et al. demonstrated that subchon-
dral osteoblasts are able to modulate the metabolismof chondrocytes and change their phenotype [13]. Of
note, the ratio of cocultured BMSC and articular chondro-
cytes regulate whether differentiation proceeds toward a
cartilaginous or osseous phenotype. Culturing articular
chondrocytes with BMSC in a 2:1 ratio induces both
phenotypes simultaneous in a three-dimensional alginate
hydrogel construct indicating that chondrocytes provide
the necessary factor(s) in this process [14]. These osteoin-
ductive properties of articular chondrocytes were also re-
ported for a culture model where chondrocytes in alginate
hydrogels were cocultured above a monolayer of BMSC
preventing direct cell-to-cell contact. Notably, the effect
was time-dependent, the longer the coculture period the
more prolonged and stable was the osteogenic phenotype
of BMSC [15].
However, the underlying mechanisms of cell-cell interac-
tions in OA joint tissues that influence chondro-osteogenic
differentiation of BMSC have not been elucidated nor fully
understood. Also, the identity of factors from OAB bone
tissue and cells that might modulate the chondrogenic
phenotype of BMSC is not comprehensively delineated.
We address this subject in the present study where we
have established a novel in vitro coculture model to evalu-
ate the influence of subchondral bone from OA-affected
joints on chondrogenic differentiation of human BMSC
derived from OA patients, the phenotype of differentiated
OA chondrocytes and the properties of newly synthesized
ECM. In addition, we have included a ‘triculture’ model
consisting of a mixture of chondrocytes and BMSC cul-
tured on subchondral bone explants. In order to attribute
effects to disease status and cell source, we reproduced
key experiments using a coculture regimen with adipose-
derived stem cells and ‘normal’ subchondral bone explants
from trauma patients. Here, we aim to test if cell-to-cell
contact between differentiated chondrocytes and undif-
ferentiated BMSC compensate effects of factors from sub-
chondral bone on chondrogenic differentiation of BMSC.
To provide a chondrogenic favorable environment, cells
were embedded in fibrin gel [16], seeded onto the surface
of subchondral bone explants and kept in chondrogenic
medium for up to 28 days.
Material and methods
Culture and isolation of human subchondral bone
explants, BMSC and chondrocytes
Human articular cartilage was collected from surgi-
cally removed joints of patients undergoing total knee
replacements (TEP) due to OA. This had been ap-
proved by the local ethics committee (Az: 08/065;
Ethikkommission an der Universität Regensburg, email:
ethikkommission@klinik.ukr.de) and specimens were taken
with patients’ written consent. For this study, knee joints
were obtained from 32 different donors (13 male and 19
female, mean age 67 ± 9). Prior to culture, the cartilage
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scopically as either damaged or intact according to a pre-
defined procedure comprising color, surface integrity and
tactile impression tested with a standard scalpel [17]. We
used only healthy-appearing pieces for isolation of chon-
drocytes and generation of subchondral bone chips. OAB
chips were produced as follows: surgically removed tissue
was thoroughly washed with phosphate-buffered saline
(PBS). Then the cartilage surface was scored as described
above and only justly evaluated pieces were accepted for
usage. Cartilage was cut off for isolation of chondrocytes
and the completely denuded bone was used for generation
of explants of 8 mm in diameter and 4 mm height. Chon-
drocytes were isolated from cartilage slices upon overnight
digestion with collagenase II (PAA, Piscataway, NJ, USA)
at 37°C. Isolated cells were resuspended in Dulbecco’s
modified Eagle’s medium (DMEM; Gibco Invitrogen,
Paisley, UK) containing 10% fetal calf serum (FCS; Sigma-
Aldrich, St. Louis, MO, USA) and 1% penicillin/strepto-
mycin (PAA, Piscataway, NJ, USA). Chondrocytes were
kept in monolayer in an initial density of 17,000 cells per
cm2 cultured in a humidified 37°C/5% CO2 incubator for
7 to 14 days and were used when confluent (passage 1).
Normal subchondral bone tissue (NB) was received from
knee joints of rare trauma-affected patients (treated
for sport accidents, two male and two female, mean age
35 ± 11) and were prepared as described above. The bone
tissue used in this study was not injured directly but was
collected during the surgical treatment of the patient from
another nonaffected region of the same joint. Preparation
of bone explants for culture was similar for OA- and
trauma-derived bone tissue.
All human BMSC used for this study have been iso-
lated from bone marrow aspirates obtained from a total
number of 30 different patients (14 male and 16 female,
mean age 61 ± 8) undergoing a hip replacement surgery
due to OA. This had been approved by the local ethics
committee (Az: 08/065; Ethikkommission an der Univer-
sität Regensburg, email: ethikkommission@klinik.ukr.de)
and specimens were taken with patients’ written consent.
The bone marrow was centrifuged and cells were fraction-
ated on a density gradient (Biocoll separating solution;
Biochrom, Berlin, Germany). The low-density cell fraction
concentrated in the interphase (‘buffy coat’) was washed,
seeded in cell culture flasks supplied with MesenchymStem
Medium (PAA, Piscataway, NJ, USA) and nonadherent
cells were removed after 5 to 7 days. Adherent cells were
cultured until they reached approximately 80% confluence.
After splitting, BMSC were seeded at a density of 4 × 104
cells/cm2 and kept in culture for up to three passages
before they were used for experiments. At this passage,
BMSC were positive for CD44 and CD105 and negative for
CD19 and CD34. Additionally, we analyzed their differen-
tiation capacity into osteogenic and adipogenic lineages.A representative specimen is shown in Figure S2 in
Additional file 1.
Adipose-derived stem cells (ASC) (isolated as described
previously by [18]) were isolated from subcutaneous fat
tissue that was obtained from patients undergoing elective
body-contouring procedures. Five different patients were
used for our coculture setup (female, age <50). Written
consent to harvest ASC from patients was obtained from
the local ethics committee (Az: 08/117; Ethikkommission
an der Universität Regensburg, email: ethikkommission@
klinik.ukr.de).
Briefly, fat tissue was washed, minced and digested
in serum-free MEM (1 ml/1 g tissue) with Liberase
Blendzyme 3 (2U/1 g tissue; Roche Diagnostics, Basel,
Switzerland) at 37°C for 45 min. The lysate was filtered
(100- and 40-μm filters; Fisher Scientific, Schwerte,
Germany) and centrifuged at 450 x g for 10 min. The cell
pellet was washed twice with Hanks’ balanced salt solution
(Cellgro, Manassas, VA, USA) and cells were seeded in
culture vials (Greiner Bio-one, Frickenhausen, Germany)
and daily washed to remove unwanted red blood cells or
nonadherent cells. After reaching a confluence of 80%,
ASC were seeded at a density of 3,000 cells/cm2, main-
tained in ASC medium (αMEM containing 20% FCS,
2 mM L-glutamine and 1% penicillin/streptomycin, Sigma-
Aldrich, St. Louis, MO, USA) and used for experiments at
passages 5.
ASC were characterized in accordance with guidelines
of the Declaration of Helsinki for biomedical research
from the Applied Stem Cell Research Center of the
University of Regensburg.
A suspension of fibrinogen (10 μl, 100 mg/ml, Sigma-
Aldrich, St. Louis, MO, USA) and 1 × 106 BMSC, 1 ×
106 ASC, 2 × 106 chondrocytes or a mixture of 5 × 105
BMSC and 5 × 105 chondrocytes (1:1) was homogenously
mixed with thrombin (18 μl, 5 U/ml; Baxter, Munich,
Germany). Because of the smaller size of chondrocytes,
their cell number had to be adjusted to obtain a com-
parable volume of fibrin gel and to avoid effects due to dif-
ferent medium diffusion capacity resulting in an altered
maintenance with nutrients. The cell-fibrinogen suspen-
sion was applied onto the surface of either OAB or NB
explants (co- and tricultures) or as a droplet on the bot-
tom of a 24-well plate (monocultures) (Figure 1). Full
polymerization was reached after 45 min at 37°C and
resulted in a stable and clear hydrogel with a pore size of
approximately 50 μm. Cell-free OAB and NB explants
were included into our setups. Mono-, co- and tricultures
as well as cell-free bone explants were kept in chon-
drogenic medium in the presence of transforming growth
factor ß (TGF-ß)-3 (10 ng/ml, R&D Systems, Minneapolis,
MN, USA) and cultured for up to 4 weeks [19]. After 7
and 28 days, a specimen of co- or tricultured fibrin gels
was carefully separated from subchondral bone explants
Figure 1 Model of contact coculture between cells and
subchondral bone explants. BMSC, mixed cultures (BMSC +
chondrocytes 1:1) and chondrocytes were embedded in fibrin gel
and these cell-gel constructs were applied onto the surface of
subchondral bone explants (co- and tricultures). As controls, cells
were embedded in fibrin gels and cultured without subchondral
bone (monocultures). All experimental setups were kept for up to
28 days in chondrogenic medium. Samples were harvested at days
7 and 28. BMSC, bone marrow-derived mesenchymal stem cells; F,
fibrin gel-embedded monocultures (without subchondral bone
explants); FB, fibrin gel-embedded co- and tricultures together with
subchondral bone explants.
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ology, immunofluorescence, biochemistry, biomechanical
or gene expression analysis as described below. Culture
supernatants of day 7 and 28 were collected and frozen
at -80°C until usage.
Cell vitality assay in fibrin gel setups
In order to evaluate vitality of cells in our different cul-
ture setups, lactate dehydrogenase (LDH) concentration
in supernatants of BMSC, mixed cultures and chondro-
cytes was determined in monocultures and co- or tricul-
tures with OAB kept in chondrogenic medium. Content
of LDH was analyzed at days 7, 14, 21 and 28 with an
LDH-based cytotoxicity detection kit (Roche Diagnostics,
Penzberg, Germany) and compared to respective assay
controls (high control = all cells in fibrin gels were lysed;
low control = spontaneous cell death of an equivalent cell
amount in monolayer) according to the manufacturer’s
instructions. LDH concentration released from dead cells
into supernatant was determined on a photometrical basis
at absorption of 490 nm (Tecan GENios with Magellan
6.5; Tecan, Crailsheim, Germany). Due to high inter-
experimental variability - presumably caused by personal
living conditions and physical activity, medical treatment
or general health status of tissue donors - we have calcu-
lated the raw data as percentage of control per individual
experiment. Repetition was in triplicate at least three
times with cells and explants from different donors.
Histology and immunofluorescence of fibrin gel-
embedded cultures
Fibrin gels were rinsed with PBS (PAA, Piscataway, NJ,
USA), embedded in TissueTec (Sakura Finetek, Alphen
aan den Rijn, the Netherlands) and were frozen in liquid
nitrogen. For histological evaluation, sections (10-μm thick)
were fixed in 4% paraformaldehyde (PFA: Sigma-Aldrich,St. Louis, MO, USA) for 10 min at RT, stained with 1%
Alcian blue 8GX (Sigma-Aldrich, St. Louis, MO, USA) for
glycosaminoglycans (GAGs) and counterstained with nu-
clear fast red aluminium sulfate solution (Roth, Arlesheim,
Germany). For immunofluorescence analysis, sections were
fixed in 4% PFA for 10 min at RT, treated for 30 min at
37°C with pepsin (3 mg/ml in 0.01 M HCl, Sigma-Aldrich,
St. Louis, MO, USA) and were blocked with 3% bovine
serum albumin (BSA) (Sigma-Aldrich, St. Louis, MO,
USA) diluted in PBS for 1 h. Sections were labeled over-
night at 4°C with an antibody against collagen I (C-2456,
Sigma-Aldrich, St. Louis, MO, USA), collagen II (CIIC1;
DSHB, Iowa City, IA, USA) or collagen III (MAB 3392;
Merck Millipore, Billerica, MA, USA). In case of collagen
X staining (2031501005; Quartett, Berlin, Germany) a
hyaluronidase (Sigma-Aldrich, St. Louis. MO, USA) pre-
treatment instead of pepsin was used. For fluorescence de-
tection, all sections were incubated with an Alexa Fluor™
488 secondary antibody (Invitrogen, Paisley, UK) for 1 h at
37°C. Finally, samples were mounted in Vectashield mount-
ing medium with DAPI (1 μg/ml, Vector Laboratories,
Burlinton, ON, Canada) and were analyzed with an
Olympus BX 61 imaging system and cellP software
(Olympus, Hamburg, Germany). Repetition was at least
five times with cells and explants from different donors.
Biochemical analysis of fibrin gel cell lysates and
supernatants
Fibrin gels were homogenized and digested with pepsin
(1 mg/ml in 0.5 M acetic acid containing 0.4 M NaCl,
Sigma-Aldrich, St. Louis, MO, USA) for 48 h at 4°C and
further digested with elastase (1 mg/ml in Tris-buffered
saline (TBS) pH 8; Serva Electrophoresis, Heidelberg,
Germany) for 24 h at 4°C. Samples were stored at -20°C
until they were analyzed for GAGs and collagen contents.
GAG concentration was measured spectrophotomet-
rically using 25 μl of the digested cell lysates or 25 μl
undiluted cell supernatant supplemented with dime-
thylmethylene blue (DMMB; AppliChem, Darmstadt,
Germany), which forms a complex with GAGs. Quantifi-
cation was performed in μg per 1 × 106 cells with a chon-
droitin sulfate standard at 525 nm (Tecan GENios with
Maggelan 6.5; Tecan, Crailsheim, Germany).
Collagen I and II contents of day 28 cell lysates digested
as described above were measured with specific sandwich
enzyme-linked immunosorbent assays (ELISAs), which
recognize the native conformation of collagen I and II
chains (Chondrex, Redmond, WA, USA), according to the
manufacturer’s instructions.
Collagen III in digested cell lysates was quantified with
a dot blot assay using 1 μl from 500 μl of cell lysate and
including a standard curve of recombinant collagen III
(Abcam, Cambridge, UK). Quantification was performed
densitometrically in μg per 1 × 106 cells using a Chemi-
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detection and the CS4 Windows software for calculation
of luminescence intensities. Repetition was in triplicate
at least five times with cells and explants from different
donors.
RNA isolation and real-time PCR amplification
Cell-fibrin gel suspensions suspended in peqGOLD
TriFast (PeqLab, Erlangen, Germany) were minced and
RNA was isolated according to a Trizol protocol, followed
by column purification with the absolutely RNA Micro-
prep Kit (Agilent Technologies Stratagene, Santa Clara,
CA, USA) according to the manufacturer’s instructions.
cDNA was generated from 500 ng of RNA using Affinity-
Script QPCR cDNA Synthesis Kit and oligo(dT) primers
(Agilent Technologies Stratagene, Santa Clara, CA, USA)
according to the manufacturer’s instructions. Repetition
was in triplicate at least five times for BMSC, mixed and
chondrocytes cocultures with bone explants from different
OA donors and at least four times for ASC cultures.
Quantitative real-time PCR was performed in triplicate
using 30 ng cDNA (RNA equivalent) and qPCR master
mix SYBR Green Dye I on MxPro-Mx305P (Agilent
Technologies Stratagene, Santa Clara, CA, USA). For
quantification, a plasmid standard curve for COL1A1,
COL2A1, COL3A1 and COL10A1 was included on each
PCR plate (plasmid copy ranges for COL1A1: 1 × 106 to
1 × 102; COL2A1: 3.4 × 107 to 3.4 × 103; COL3A1: 1 × 106
to 1 × 102 and COL10A1: 5 × 104 to 5 × 100). Gene ex-
pression of matrix metalloproteinase (MMP)2, MMP3,
MMP13 and aggrecan (ACAN) gene was normalized
with GAPDH and data evaluation was relative employing
the ΔΔCT method using gene expression of unstimu-
lated monocultures as calibrator. Data analysis was car-
ried out with the MxPro QPCR 4.0 software (Agilent
Technologies Stratagene, Santa Clara, CA, USA). The
following forward and reverse primer pairs were used
for gene expression analysis: for COL1A1 5′-AGC TCC
TGG TGA AGT TGG TC-3′ and 5′-ACC AGG GAA
GCC TCT CTC TC-3′; for COL2A1 5′-TGC TGC CCA
GAT GGC TGG AAG A-3′ and 5′-TGC CTT GAA
ATC CTT GAG GCC C-3′; for COL3A1 5′-GTC CAT
GGA TGG TGG TTT TC -3′ and 5′-GTG TGT TTC
GTG CAA CCA TC-3′; for COL10A1 5′-CCC TCT
TGT TAG TGC CAA CC-3′ and 5′-AGA TTC CAG
TCC TTG GGT CA-3′; for MMP2 5′-GCC AAT GGA
GAC TGT CTC AAG A-3′ and 5′-TTC TAA GGC
AGC CAG CAG TGA A-3′; for MMP3 5′-AAC CTG
TCC CTC CAG AAC CT-3′ and 5′-GGAAGA-
GATGGCCAAAATGA-3′; for MMP13 5′-CAC CGG
CAA AAG CCA CTT-3′and 5′-TAGAC TGG TAA
TGG CAT CAA GGG A-3′; for ACAN 5′-CTA TAC
CCC AGT GGG CAC AT-3′ and 5′-GGC ACT TCA
GTT GCA GAA GG-3′and for GAPDH 5′-ACC CAGAAG ACT GTG GAT GG-3′ and 5′-TTC TAG ACG
GCA GGT CAG GT-3′.
Analysis of soluble collagens in culture supernatants with
hydroxyproline assay
The amount of total soluble collagen in culture superna-
tants was determined by the Total Collagen Hydroxypro-
line Assay (QuickZyme Biosciences, Leiden, Netherlands)
according to the manufacturer’s protocol. Briefly, after
3 days, 1 ml culture supernatant from monocultures or
subchondral bone cocultures was harvested and soluble
collagens in the supernatant were hydrolyzed into amino
acids (12 M HCl for 20 h at 95°C). Hydroxyproline was
stained and color formation was quantified at absorbance
maximum at 570 nm (Tecan GENios with Maggelan 6.5;
Tecan, Crailsheim, Germany). Repetition was in triplicate
at least five times with cells and explants from different
donors.
Analysis of culture supernatants for bFGF, IL-1ß, IL-6
and IL-8
To determine the concentration of specific proteins in
the supernatant, human interleukin-1ß (IL-1ß) sandwich
ELISA kit (Ray Biotech, Inc., Norcross, GA, USA),
interleukin-6 (IL-6) sandwich ELISA kit (R&D Systems,
Minneapolis, MN, USA), interleukin-8 (IL-8) ELISA kit
(Gen-Probe, Bedford, MA, USA) and basic fibroblast
growth factor (bFGF) sandwich ELISA kit (R&D Systems,
Minneapolis, MN, USA) were used according to the man-
ufacturer’s instructions. Repetition was in triplicate at least
six times for BMSC, mixed cultures and chondrocytes
cocultured with bone explants from different OA donors
and at least four times for cell-free OA and normal bone
explants as well as for ASC cultures.
Biomechanical testing
Samples with a standardized outer diameter of 2.6 mm
were punched out of the fibrin gel-cell constructs (biopsy
punch, Stiefel, Munich, Germany). The biomechanical
tests were carried out in a standard material testing ma-
chine (Z010; Zwick, Ulm, Germany) equipped with a 40 N
load cell. The initial sample height (h0) was assessed under
a preload of 0.1 N by use of a laser displacement trans-
ducer (optoNCDT 2200-20; Micro-Epsilon Messtechnik
GmbH & Co., Ortenburg, Germany, 0.3 μm resolu-
tion, ±0.03% accuracy). Subsequently, the samples were
placed in a cell culture dish filled with 0.9% NaCl and an
unconfined compression test was performed by loading it
through a flat-ended punch at a strain rate of 100% h0/min
until 50% strain was reached. The Young’s modulus was
then calculated at two typical regions from the stress-strain
diagrams (progressive region at 0 to 10% strain and the
linear region at 40 to 50% strain). The samples were then
stored for 24 h at 4°C in physiological saline to let them
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ation test was performed. The samples were placed in a
confining chamber of 2.6 mm diameter filled with 0.9%
NaCl and loaded by a porous ceramic cylinder (Al2O3)
allowing for fluid exudation. Fifty percent strain was
applied at a strain rate of 100% h0/min and held constant
for 10 min until the equilibrium state was reached. Then
the hydraulic permeability (k) was determined using a
least squares algorithm derived from a diffusion equation
[20,21] (Formula 1), where Δl/h0 is the applied strain
and t the time. The aggregate modulus (HA) at equilib-
rium state at 50% strain was calculated as described in
Formula 2 where σ∞ was the equilibrium stress at a strain
of 50%. Repetition was four times with cells and explants
from different donors.




 H K  t
 
Formula 2 HA ¼ σ∞
ε50%
Stimulation of BMSC, mixed cell populations and
chondrocytes embedded in fibrin gel
Stimulation of monocultures with IL-1ß (5 ng/ml,
Biomol, Hamburg, Germany), IL-6 (5 ng/ml, RayBiotech,
Norcross, GA, USA) or IL-8 (10 ng/ml, RayBiotech,
Norcross, GA USA) was performed in chondrogenic
medium for the first 7 days. Fibrin gels were harvested
after 7 or 28 days and processed for gene expression ana-
lysis as described above. Repetition was in triplicate at
least five times with cells and bone explants from different
donors.
Culture setups of ASC with subchondral bone
ASC were seeded onto the surface of OAB or NB explants
as described above. Fibrin gels of days 7 and 28 were proc-
essed for qPCR and culture supernatants were collected
and frozen at -80°C until usage for analysis of cytokines,
bFGF and GAG.
Stimulation of BMSC with conditioned medium
BMSC monocultures were supplemented either with
fresh chondrogenic medium or with chondrogenic medium
that was conditioned for three days by OAB explants.
Monocultures and stimulated cultures were kept under
these conditions for up to 28 days and medium was chan-
ged every 3 days. After 7 and 28 days, fibrin gels were
processed for gene expression analysis as described above.
Repetition was in triplicate at least four times with cells
and explants from different donors.
Statistical analysis
All results are calculated for an initial cell number of
1 × 106 cells. The mean standard deviation (SD) valueswere calculated for all variants. The nonparametric
Wilcoxon test (for paired analyses) or the Mann-Whitney
test (unpaired analyses) was applied to analyze differ-
ences between time points and between culture con-
ditions. All experiments were performed in triplicate
and repeated at least four times with cells from dif-
ferent donors. P <0.05 values were considered to indi-
cate statistically significant differences. Data analysis
and graphing was performed with GraphPad for Windows
version 5 (GraphPad Software, Inc., La Jolla, CA, USA).
Results
Viability of cultured cells
In order to evaluate if the fibrin gel system affects
vitality/viability of cells, LDH concentration in culture
supernatants was analyzed and compared to respective
monolayer controls. Chondrocytes, BMSC and mixed
cultures embedded in fibrin gel cocultured or kept as
monocultures showed no enhanced LDH release com-
pared to assay controls. We therefore assume that cells
are not influenced in their vitality or overall metabolic
activity by fibrin gel components or subchondral bone
explants during the culture time period (Figure S1A-C
in Additional file 2).
Culture models
We set up different culture conditions to analyze the
influence of factors from subchondral bone on multi-
potent BMSC with respect to ECM formation and
chondrogenic differentiation. Therefore, we cocultured
BMSC embedded in fibrin gel with subchondral bone
explants from OA patients. As a control for chondro-
genic properties of BMSC we used cocultures of dif-
ferentiated articular chondrocytes and mixed cultures
(tricultures) of chondroctyes and BMSC (both em-
bedded together in fibrin gels) to include putative
cell-to-cell effects of differentiated cells on undifferen-
tiated cells. As a control for cocultures we set up the
respective monocultures of cells embedded in fibrin
gels and cultured in chondrogenic medium (Figure 1).
Additionally, we analyzed cell-free subchondral bone
explants from OA and trauma donors with respect to
cytokines, soluble (s)GAG and bFGF release and in-
cluded an ASC coculture set up with OAB and NB
explants with respect to gene expression and release of
cytokines, sGAG and bFGF.
Collagen gene expression of cocultures versus
monocultures
To determine whether factors released from subchondral
bone (OAB or NB) affect matrix production or chondro-
genic differentiation of ASC or BMSC and chondrogenic
phenotype of chondrocytes, mRNA expression of COL1A1
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drogenic differentiation), COL3A1 (mesenchymal marker)
and COL10A1 (marker for chondrocyte hypertrophy) was
analyzed at days 7 and 28.
At day 7, we observed a significant inhibition of
COL1A1 gene expression in ASC and BMSC cocultured
with OAB and in mixed tricultures compared to monocul-
tures, whereas ASC cocultured with NB and chondrocyte
OAB cocultures remained unaffected. At day 28 none of
the culture conditions that affected COL1A1 gene expres-
sion was statistically significant. ASC cocultured with NB
had higher mRNA level of COL1A1 compared to mixed
tricultures at day 28 while all other OAB coculture condi-
tions revealed no significant difference to NB cocultures
(Figure 2A). Analyses of COL2A1 gene expression in OAB
cocultures revealed a significant upregulation in ASC
cocultures and a significant downregulation in BMSCFigure 2 Quantification of gene expression with qPCR. Gene expressio
determined in mono-, co- and tricultures at day 7 (blank bars) and day 28
BMSC (white bars), mixed cultures (BMSC and chondrocytes in a ratio of 1:1, d
(dotted lines at 100%) or as co- and tricultures (FB) with NB or OAB explants i
have calculated the raw data as a percentage of highest cDNA copy number
(*) indicate significant differences between mono- and cocultures, hash signs
Results are mean with standard deviation (SD). N =5; *P <0.05, **P <0.01, ***P <
mesenchymal stem cells; FB, fibrin gel-embedded co- and tricultures togethe
osteoarthritic subchondral bone.cocultures compared to respective monocultures at day
28. COL2A1 gene expression in all other culture regimen
remained unaltered. No significant differences in COL2A1
gene expression were detectable between NB and OAB
cocultures (Figure 2B).
In all co- and tricultures COL3A1 gene expression was
significantly downregulated at day 7 and in mixed tricul-
tures and chondrocyte cocultures also at day 28 compared
to monocultures. No significant differences in COL3A1
gene expression were detectable between NB and OAB
cocultures (Figure 2C).
COL10A1 gene expression was reduced in NB cocul-
tures with ASC at day 28 and in OAB cocultures with
ASC and BMSC at day 7 and in BMSC and chondrocyte
cocultures at day 28 compared to respective mono-
cultures. In ASC cocultured with NB, COL10A1 gene
expression was increased compared to OAB coculturesn level of (A) COL1A1, (B) COL2A1, (C) COL3A1 and (D) COL10A1 were
(bars with pattern) using plasmid standard curves. ASC (light grey bars),
ark grey bars) and chondrocytes (black bars) were kept as monocultures
n chondrogenic medium. Due to high interexperimental variability we
per individual experiment and to 100% of monocultured controls. Stars
(#) indicate significant differences between NB and OAB cocultures.
0.001. ASC, adipose-derived stem cells; BMSC, bone marrow-derived
r with subchondral bone explants; NB, normal subchondral bone; OAB,
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OAB coculture conditions revealed no significant differ-
ence to NB cocultures (Figure 2D).
Overall, we observed an inhibitory effect of OAB ex-
plants on collagen gene expression in co- and tricultures
whereas NB explants affected collagen gene expression
less.
Quantification of collagen and proteoglycan synthesis in
cell lysates
In further experiments, we studied the influence of OAB
explants on collagen (day 28) and GAG/proteoglycan
(days 7 and 28) synthesis.
We detected a significantly reduced collagen I produc-
tion in BMSC cocultures and mixed tricultures in com-
parison to monocultures. In chondrocytes, collagen I
synthesis was below assay detection limit in both culture
conditions (Figure 3A). We observed a significantly
reduced collagen II production in BMSC and chondro-
cyte cocultures compared to monocultures while mixedFigure 3 Quantification of collagens I, II, III and proteoglycans in cell
lysates after 28 days of culture in fibrin gels and GAGs (D) in cell lysates on
a ratio of 1:1, grey bars) or chondrocytes (black bars) were embedded in fib
triculture with OAB explants (FB, blank bars) in chondrogenic medium. (A, B)
evaluated dot-blot analysis containing a recombinant collagen III standard cu
a DMMB assay including a chondroitin sulfate standard curve. Results are mea
BMSC, bone marrow-derived mesenchymal stem cells; DMMB, dimethylmethy
bone explants); FB, fibrin gel-embedded co- and tricultures together with sub
subchondral bone.tricultures remained unaffected (Figure 3B). Collagen III
production in all three co- and triculture conditions
was significantly reduced compared to monocultures
(Figure 3C). A dimethylmethylene blue (DMMB) assay
demonstrated that all co- and triculture cell lysates had a
significantly decreased GAG/proteoglycan content on day
7 (Figure 3D) while on day 28 no significant differences
were detected between mono-, co- and tricultures (data
not shown).
Overall, we observed an inhibitory effect of OAB on
collagen and proteoglycan synthesis in co- and tricul-
tured cells.
Immunofluorescence staining of collagens and
histological staining of GAG
Collagen deposition into the ECM of mono-, co- and
tricultures was demonstrated by immunofluorescence
of cryosections at day 28.
BMSC and mixed monocultures deposited a higher
amount of collagen I into their ECM than those co- orlysates. Protein synthesis of collagens I (A), II (B) and III (C) in cell
day 7. BMSC (white bars), mixed cultures (BMSC and chondrocytes in
rin gel and kept in monoculture (F, bars with pattern) or in co- and
Collagens I and II were quantified with ELISA, or (C) by densitometrically
rve. (D) Proteoglycan/GAG concentration in cell lysates was quantified by
n with standard deviation (SD). N =5; *P <0.05, **P <0.01, ***P <0.001.
lene blue; F, fibrin gel-embedded monocultures (without subchondral
chondral bone explants; GAG, glycosaminoglycan; OAB, osteoarthritic
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in chondrocytes was poor in both culture conditions
(Figure 4A). Staining for collagen II was detected in
all monoculture conditions and poor or no staining in
co- and tricultures with OAB explants (Figure 4B).
We observed similar collagen III staining in all mono-
culture conditions but only little or no staining in the
co- and triculture setups (Figure 4C). A similar trend was
detected for collagen X, which was positively stained in
BMSC and mixed monocultures but only weak in chon-
drocyte monocultures and co- and tricultures (Figure 4D).
Alcian blue staining was used to detect proteoglycan/
aggrecan deposition in the fibrin gel constructs. All cul-
ture conditions were uniformly stained blue and showed
no differences between monocultures and OAB co- and
tricultures (Figure 4E).
Overall, we observed reduced collagen deposition into
the ECM in co- and tricultured fibrin gels during the
culture period compared to monocultures.Figure 4 Immunofluorescence staining of collagens. Representative im
and of Alcian blue (E) in fibrin gels of BMSC, mixed cultures (BMSC + chond
OAB (FB) or monoculture (F) (Scale bar is 100 μm). BMSC, bone marrow-de
(without subchondral bone explants); FB, fibrin gel-embedded co- and tricu
subchondral bone.Biomechanical properties
We determined the integrity and load capacity of newly
generated ECM by measuring its biomechanical proper-
ties. Unconfined mechanical testing indicated that OAB
cocultures exhibited a decrease in Young’s modulus at
0 to 10% strain in four of four samples (BMSC) and three
of four samples (mixed tricultures and chondrocytes)
(Figure 5A). Young’s modulus at 40 to 50% strain showed
a decrease in BMSC and mixed OAB co- and tricultures
(four of four) while Young’s modulus of chondrocytes
(three of four) was increased (Figure 5B). Aggregate
modulus at equilibrium was reduced in all OAB co-
and tricultures compared to monocultures (Figure 5C).
Further, three of four BMSC OAB coculture samples
had a more than threefold hydraulic permeability com-
pared to monocultures while no clear differences in
hydraulic permeability were detected for mixed and
chondrocyte OAB co- and tricultures compared to
monocultures (Figure 5D).munofluorescence staining of collagens I (A), II (B), III (C) and X (D)
rocytes 1:1) and chondrocytes after 28 days of co- and triculture with
rived mesenchymal stem cells; F, fibrin gel-embedded monocultures
ltures together with subchondral bone explants; OAB, osteoarthritic
Figure 5 Determination of biomechanical properties. Biomechanical properties of the newly formed ECM at day 28 of BMSC, mixed cultures
and chondrocytes co- or tricultured with OAB explants were analyzed and calculated to 100% of monocultured controls (dotted lines at 100).
Young’s modulus of (A) 0 to 10% and (B) 40 to 50% strain were determined using unconfined compression. Aggregate modulus at equilibrium
(C) and hydraulic permeability (D) were determined using confined compression performed at 50% compression. N =4. BMSC, bone marrow-derived
mesenchymal stem cells; ECM, extracellular matrix; OAB, osteoarthritic subchondral bone.
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supernatants
In supernatants of ASC, BMSC, mixed cultures and
chondrocytes co- or tricultured with OAB explants, we
detected significantly more IL-1ß at day 28 compared to
monocultures whereas NB did not affect IL-1ß release.
In addition, mixed tricultures and chondrocyte cocultures
with OAB released more IL-1ß into the culture super-
natant compared to ASC cocultures with NB (Figure 6A).
We detected a significant higher IL-6 level in NB cocul-
tures of ASC compared to all other OAB co- and tricul-
ture regimen at day 7. In addition, all coculture
regimens (except for ASC + OAB) released more IL-6
into the culture supernatants compared to monocultures
at day 7 (Figure 6B). IL-8 concentrations in supernatant of
NB cocultures with ASC and OAB cocultures with
BMSC and chondrocytes at day 7 were significantly
elevated compared to monocultures. Moreover, IL-8
level in ASC cocultured with OAB was significant
lower than in ASC cocultured with NB (Figure 6C).
ASC, BMSC and chondrocyte NB and OAB cocultures re-
leased more bFGF into supernatants in comparison to
monocultures. In supernatants of OAB cocultures with
BMSC, significantly higher levels of bFGF were detected
compared to ASC cocultures with NB (Figure 6D). We de-
tected a significantly higher soluble GAG (sGAG) level in
supernatants of all co- and tricultures at day 7, however,
no significant differences between NB and OAB cocul-
tures were detectable (Figure 6E). Analysis of supernatants
for total soluble collagen content or soluble fibronectin
content did not reveal differences (data not shown).In supernatants of cell-free OAB and NB explants,
IL-1ß concentration was in the low pg/ml range but
was significantly higher in supernatants of OAB com-
pared to NB at day 7. IL-1ß release increased in NB
explant supernatants during culture time (Figure 7A).
There was no difference with respect to release of IL-6
and IL-8 between cell-free OAB and NB explants. How-
ever, concentration of both cytokines decreased in super-
natants during culture time (Figure 7B and C). bFGF
concentration in supernatants of cell-free OAB explants
was significantly higher than in NB explants at both time
points. Additionally, bFGF concentration significantly de-
creased in supernatants of both, OAB and NB explants
from day 7 to day 28 (Figure 7D). Cell-free NB explants
revealed at both time points a significantly higher level of
GAGs in supernatants compared to OAB explants
(Figure 7E).
Overall, we observed an increased level of IL-1ß, IL-6,
IL-8, bFGF and GAG in supernatants of co- and tri-
cultures. Cell-free NB or OAB explants released these
factors indicating an additive effect of bone tissue and
co- or tricultured cells. Additionally, we detected dif-
ferences in cell-free OAB explants compared to NB
culture supernatants for IL-1ß, bFGF and soluble GAG
concentrations.
Stimulation of fibrin gel-embedded monocultures with
IL-1ß, IL-6 and IL-8
To determine whether IL-1ß, IL-6 or IL-8 has an effect
on gene expression, we stimulated BMSC, mixed and
chondrocyte monocultures with these cytokines and
Figure 6 Quantification of cytokines, bFGF and GAGs in culture supernatants. Analysis of supernatants at days 7 or 28 of ASC (light grey
bars), BMSC (white bars), mixed cultures (BMSC and chondrocytes in a ratio of 1:1, dark grey bars) or chondrocytes (black bars) monocultured
(F, bars with pattern) and co- or tricultured with NB or OAB explants (FB, blank bars). Total amounts of cytokines (A) IL-1ß, (B) IL-6, (C) IL-8), (D)
bFGF released into the supernatant were quantified by antigen-specific ELISAs. Analysis of soluble GAG was carried out using a DMMB-assay
containing a chondroitin sulfate standard curve for quantification (E). Stars (*) indicate significant differences between mono- and cocultures, hash
signs (#) indicate significant differences between NB and OAB cocultures. Results are mean with standard deviation (SD). N =6; *P <0.05, **P <0.01,
***P <0.001. bFGF, basic fibroblast growth factor; BMSC, bone marrow-derived mesenchymal stem cells; DMMB, dimethylmethylene blue; ELISA,
enzyme-linked immunosorbent assay; F, fibrin gel-embedded monocultures (without subchondral bone explants); FB, fibrin gel-embedded
co- and tricultures together with subchondral bone explants; GAG, glycosaminoglycan; NB, normal subchondral bone; OAB, osteoarthritic
subchondral bone.
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and MMP13 at culture day 7.
We observed a significant inhibition of ACAN gene
expression in IL-1ß-stimulated BMSC and mixed cultures
in comparison to unstimulated controls. An increase of
MMP2 gene expression was detected in IL-1ß-stimulatedBMSC and mixed cultures while MMP3 gene expression
was induced in all three culture regimens compared to
unstimulated controls. We observed a significant induc-
tion of MMP13 gene expression in IL-1ß-stimulated
BMSC and chondrocytes whereas MMP13 was downregu-
lated in mixed cultures (Figure 8A).
Figure 7 Quantification of cytokines, bFGF and GAGs in cell-free bone supernatants. Concentration of (A) IL-1ß, (B) IL-6 and (C) IL-8, (D)
bFGF and soluble (E) GAGs was determined in cell-free OAB explants (white bars) and NB explants (bars with pattern) kept in chondrogenic
medium for 7 or 28 days. Results are mean with standard deviation (SD). N =4; *P <0.05; **P <0.01; ***P <0.001. bFGF, basic fibroblast growth factor;
GAG, glycosaminoglycan; IL, interleukin; NB, normal subchondral bone; OAB, osteoarthritic subchondral bone.
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chondrocyte monocultures compared to unstimulated
controls only. MMP2 gene expression in all three culture
conditions remained unchanged. In contrast, MMP3
expression was downregulated in mixed cultures and
chondrocytes in comparison to unstimulated mono-
cultures. IL-6 stimulation reduced MMP13 gene expres-
sion in BMSC monocultures compared to unstimulated
controls (Figure 8B).
Stimulation with IL-8 induced ACAN gene expression in
BMSC. MMP2 gene expression was significantly increasedin mixed cultures while MMP3 gene expression in all
other culture conditions remained unaffected. Stimulation
with IL-8 increased MMP13 gene expression in mixed
cultures (Figure 8C).
Overall, we observed a mostly inhibitory effect of IL-1ß
and IL-6 on gene expression of ACAN. MMP2, MMP3 and
MMP13 gene expression was induced mainly by IL-1ß while
IL-6 has no effect on MMP2 expression and rather down-
regulates MMP3 and MMP13 gene expression. IL-8 stimu-
lation has also only little effect on gene expression except
for a partly induction of ACAN,MMP2 andMMP13.
Figure 8 Stimulation of fibrin gel monocultures with IL-1ß, IL-6
or IL-8 for 7 days. BMSC (white bars), mixed cultures (BMSC +
chondrocytes 1:1, grey bars) or chondrocytes (black bars) embedded
in fibrin gel were stimulated for 7 days with 5 ng/ml IL-1ß, 5 ng IL-6
or 10 ng IL-8 in chondrogenic medium-containing dexamethasone
and TGF-ß-3. Specimens were analyzed for gene expression of
aggrecan (ACAN), matrix metalloproteinase (MMP)2, MMP3 and
MMP13 at day 7. The log fold change (log2) was calculated via a
calibrator that represents the unstimulated monocultures and is
represented by a line at 0. Results are mean with standard deviation
(SD). N =5; *P <0.05, **P <0.01, ***P <0.001. BMSC, bone marrow-derived
mesenchymal stem cells; IL-1ß, interleukin; IL-6, interleukin-6; IL,
interleukin-8; TGF, transforming growth factor.
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conditioned medium
Fibrin gel-embedded BMSC monocultures supplemented
with OAB conditioned medium (CM) were analyzed for
gene expression of collagens.At day 7, no differences between BMSC monocultures
with and without conditioned medium were observed
concerning gene expression of all analyzed collagens.
Notably, at day 28 BMSC incubated with CM from OAB
revealed a significantly reduced gene expression of all ana-
lyzed collagens compared to nonconditioned medium
(Figure S3A-D in Additional file 3).
In addition, we detected a significant upregulation of
COL2A1 and COL10A1 gene expression from day 7 to
day 28 in nonconditioned cultures whereas COL3A1 was
significantly downregulated. Inhibition of COL2A1 and
COL3A1 gene expression at day 28 compared to day 7
was also detected in cultures with CM (Figure S3B-D in
Additional file 3).
Overall, we observed a clear inhibitory effect of OAB
CM on gene expression of all collagens at day 28.
Table S1 in Additional file 4 summarizes all P values in-
dicated in Figures 2, 3, 6, 7, 8 and Figure S3 in Additional
file 3.
Discussion
A so far unmet challenge in the treatment of OA-affected
joints is to replace the degraded articular cartilage and
subchondral bone matrix with healthy cartilage/bone
tissue in order to restore impaired joint function and
to prevent or delay total joint replacement by artificial
endoprothesis. Cell-based treatment such as autolo-
gous chondrocyte implantation (ACI), microfracturing
of trauma-induced focal chondral or osteochondral lesions
in younger patients prior to establishment of posttrau-
matic OA is established and leads in general to production
of cartilage- and subchondral bone-like replacement tissue
[22,23]. However, there are conflicting data about long-
term stability and functionality of specifically cartilage
repair tissue as the composition resembles fibrocartilage
rather than hyaline cartilage [24,25]. In addition, for older
patients or those affected with OA, these treatment
options are not successful due to failure or inferior
osteochondral defect healing [26]. The reasons for
poor healing and repair outcome of cell-based therapies,
especially in OA joints, are not comprehensively under-
stood. One likely reason are profoundly altered microenvi-
ronmental cues from the surrounding subchondral bone
tissue.
In the present study, we analyzed the impact of OAB
on chondrogenic differentiation of BMSC, the phenotype
of differentiated chondrocytes and matrix-forming cap-
acity. We investigated the influence of OAB joints on
BMSC and chondrocytes assuming that factors produced
by OA osteoblasts, osteocytes or osteoclasts can modulate
metabolic properties of these cells. It is striking that OAB
inhibits gene expression and protein production of colla-
gens I, II, III and X in most co- and triculture setups com-
pared to monocultures. This decrease of collagens is not
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to have an in vivo half-life of more than 100 years [27] as
a hydroxyproline assay did not reveal increased level of
soluble collagens in culture supernatants, indicating that
reduced biosynthesis is the major reason for reduced col-
lagen matrix deposition, which in turn causes diminished
accumulation of collagen protein in the ECM during the
culture time. Since the half-life of collagen mRNA is often
only several hours [28], differences in collagen protein
level at the culture endpoint are not mandatorily mirrored
at mRNA level assessed at the same time.
As synthesis of all investigated collagen types was
suppressed in the presence of OAB (albeit collagen X
production was not quantified), no effect specifically
on chondrogenic differentiation of BMSC by subchondral
bone can be postulated but a general effect on synthesis of
matrix macromolecules. Similar inhibitory effects of OA
cartilage explants on the production of collagens were
described in a recent study by Leyh et al. [29].
When repeating key experiments (gene expression
studies and cytokine release) with ASC and NB explants
we were unable to detect alterations in gene expression
of collagens I and II in coculture with NB suggesting
that inhibition, respective alteration of these collagens in
ASC cocultures with OAB is related to factors specific
for OA.
The interaction between subchondral bone cells and
chondrocytes on the molecular level has not been well
understood until now. But there are likely important
regulatory events after cartilage injury initiated by
subchondral bone cells. In line with our observations,
Jiang et al. revealed a suppression of specific markers
in cocultures of chondrocytes and osteoblasts like dimin-
ished GAG and collagen II deposition or mineralization of
ECM [30]. Coculturing of OA chondrocytes with OA
osteoblasts induces inhibition of aggrecan production and
a concomitant significant increase in MMP13 synthesis.
The cocultured osteoblasts also decrease COL2A1, SOX9
and PTHrP/PTH-receptor gene expression in the chondro-
cytes [31,32]. In addition to their data, we observed that in
cocultures with subchondral bone (OAB and NB) and in
cultures with OAB CM gene expression of COL10A1 was
strongly inhibited compared to monocultures. A specific
collagen X-suppressing effect by paracrine coculture of
BMSC with healthy articular cartilage was reported earlier
from our group and thus appears not to be restricted
to bone but to as yet unidentified soluble factor(s)
that are common to both tissue types and that are OA
independent [19].
Notably, besides reduced synthesis of GAGs in cocul-
tured cell lysates at early time points, we also detected in-
creased sGAGs in supernatants of cocultures. However,
as OAB and NB cultured without cells also released
sGAGs into the supernatant, we believe that we observedan additive effect of cells and explants and not a true
increase in degradation of proteoglycans. This is under-
scored by our observations with ASC cocultures and also
by Alcian blue histology, which did not reveal differences
between culture conditions at the end of culture (day 28)
but at the beginning and by biomechanical properties
with respect to permeability and fluid exchange (see
below). Therefore, we assume no increase in degradation
of proteoglycans and suggest that early inhibition of GAG
synthesis is compensated in cocultures during the time
line of culture.
We observed an increased release of bFGF in cocul-
tures of BMSC, ASC and chondrocytes with OAB and in
cocultures of ASC with NB explants at the early phase
of culture, which is in line with a previous study [33]. As
we found also release of bFGF from OAB and NB
explants cultured without cells, we assume that this adds
to the bFGF detected in cocultures. bFGF and other
growth factors might be released together with the GAGs
they were bound to during pathophysiological situations,
that is after tissue injury or during chronic inflammation
[34]. Moreover, NB explants released less bFGF compared
to OAB explants indicating a true induction of bFGF re-
lease from ASC specifically in the presence of normal
bone cells.
Reduced synthesis of matrix components is likely to
influence mechanical properties and stability of the result-
ing matrix. Most important for a successful osteochondral
repair is the mechanical stability of the new tissue. The
ECM of cartilage consists primarily of three molecules:
water, type II collagen and the proteoglycan aggrecan
[35,36]. Under strain, load is first carried by water, which
is displaced from the tissue and leaves the matrix, which
carries the load after water has gone from the tissue.
Therefore both are physiologically important: water con-
tent and its retention in the extrafibrillar matrix together
with stability of the fibrillar network. We observed that
Young’s modulus was reduced in OAB cocultures of
BMSC and mixed cultures whereas aggregate modulus
was reduced in all cocultures. Hydraulic permeability
showed no clear trend for OAB tricultures and chon-
drocyte OAB cocultures. Erickson et al. showed that in
every case, BMSC-laden constructs possessed mechanical
properties significantly lower than those of chondrocyte-
seeded hydrogel constructs [37], which is in line with our
findings. Our results suggest that coculture with subchon-
dral bone leads to reduced loading capacity of matrix, with
increased permeability at least for the BMSC coculture. In
contrast, OAB-cocultured chondrocytes showed a trend
to increased Young’s modulus (depending on strain
applied), while hydraulic permeability and aggregate
modulus also remained unchanged by subchondral bone
coculture. OAB-cocultured chondrocytes seem to pro-
duce a matrix with mechanical properties that resemble
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that it is comparable to an ECM synthesized by healthy
chondrocytes. Taken together, our data suggest that cocul-
ture with OAB impairs mechanical matrix properties with
respect to the newly formed fibrillar collagenous network
and not of the proteoglycan rich extrafibrillar matrix. This
is in line with a previous study from our group, which
indicates a distinct modulatory influence of OA cartilage
explants that affects the collagen composition of the de
novo-produced ECM from co- and tri-cultured cells and
leads to impaired mechanical and biochemical properties
of the matrix because of an altered fibrillar network [29].
Although many studies have examined effects of fac-
tors released from cartilage and chondrocytes on chon-
drogenesis, only few have focused on the influence of
proinflammatory cytokines from subchondral bone on
the chondrogenic differentiation and matrix-forming
capacity of BMSC [38,32]. In the current study, we
analyzed proinflammatory cytokines like IL-1ß, IL-6
and IL-8, which are known to be released from BMSC and
OA chondrocytes and are considered to contribute to OA
pathogenesis [39,40]. We discovered that coculture with
OAB truly induced the concentration of these cytokines/
chemokines in culture supernatants in all culture con-
ditions. This was most prevalent in the early phase of
the culture except for IL-1ß, which remained induced
throughout the culture time. Notably, comparison of in-
flammatory factors released by OAB and NB explants in
cell-free and coculture experiments revealed differences.
First, cell-free NB explants released less IL-1ß and bFGF
but more GAGs than OAB and - importantly - NB did
not induce IL-1ß release in coculture. Second, IL-6 and
(partly) IL-8 release in cocultures with NB explants was
higher than release from OAB cocultures. Presumably,
these metabolic differences result from a differently
composed ECM of bone tissue from younger trauma
patients, including increased osteoblast numbers and
activity resulting in a higher bone-forming capacity
compared to older OAB [41,42]. We suggest that these cy-
tokines in part mediate suppression of collagen and GAG
synthesis and induce GAG release from proteoglycans,
which would be in line with data from literature [32,43].
To prove our hypothesis, we stimulated monocultures of
BMSC, mixed cells and chondrocytes - embedded in fibrin
gel - with IL-1ß, IL-6 or IL-8. We observed that stimula-
tion with IL-1ß in general induced MMP2, MMP3 and
MMP13 gene expression, which all are important players
with respect to matrix degradation. Additionally, IL-1ß-
stimulation of BMSC and of mixed cultures leads to a
significant downregulation of ACAN gene expression,
which is in line with most recent literature [39], however,
Salter et al. reported involvement of IL-1ß in a chondro-
protective signaling cascade, which is defined by increas-
ing ACAN mRNA in chondrocytes [44]. In concert withIL-1ß, IL-6 inhibits proteoglycan production and can in
addition amplify IL-1ß effects [39]. We observed that IL-6
effects on ACAN gene expression were less pronounced
as after IL-1ß stimulation. MMP2 expression was not af-
fected while MMP3 and MMP13 expression were mostly
downregulated after IL-6 stimulation. This is in line with
studies that predict that IL-6 might have also a beneficial
role in OA pathology. OA chondrocytes produce more
IL-6 during cartilage regeneration than healthy chon-
drocytes. A recent study of Tsuchida et al. revealed a
modest anabolic role for IL-6 in cartilage matrix regen-
eration demonstrating that chondrocytes produce high
amounts of IL-6, which is released into the synovial fluid
and has possible beneficial effects on cartilage regener-
ation [45]. It appears that chondrocytes react more sen-
sitive to OA conditions as we observed no differences in
IL-6 and IL-8 level in OAB versus NB bone explant
supernatants.
We demonstrated inductive effects of IL-8 on gene
expression of mixed cultures for MMP2 and MMP13
and of BMSC for ACAN, while chondrocytes did not
respond. IL-8 initiates chemotaxis in cells and leads to
cell migration aligned with MMP upregulation. This
could be interpreted as a trial for cartilage repair with
local BMSC and suggests, that IL-8 is required to initiate
tissue repair in vivo [46]. Notably, chondrocytes seemed
to be not affected by IL-8 stimulation possibly, because
OA chondrocytes are less sensitive to cytokine stimulation
than normal cells [47].
In addition, we wanted to answer the question if differ-
entiated chondrocytes, which are in close cell-to-cell
contact with undifferentiated BMSC ameliorate or aug-
ment inhibitory effects of subchondral bone explants on
BMSC. Overall, we observed that collagen gene expres-
sion was mostly unaltered while protein expression and
biomechanical properties of OAB tricultured mixed
populations resemble rather OAB cocultured BMSC
than chondrocytes. We thus suggest that chondrocytes
in the mixed cultures do not alter BMSC metabolism in
tricultures with subchondral bone explants and that re-
sponse of mixed cultures to factors from OAB resemble
rather that of cocultured BMSC than that of cocultured
chondrocytes.
In order to include a ‘reference’ for BMSC that were
all obtained from OA-affected donors, we repeated key
experiments with ASC which served as ‘healthy’ controls.
We did not find striking differences between both cell
types with respect to influence of coculture on colla-
gen gene expression and cytokine, bFGF and GAG re-
lease. Thus we suggest that tissue source (ASC versus
BMSC) and age and disease status (OA versus non-OA)
of cell donors do not affect matrix-forming capacity
and chondrogenic differentiation at least under in vitro
conditions.
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OA, we have repeated key experiments with subchondral
bone from trauma patients. We observed differences in
release of IL-1ß, bFGF and GAG between OAB and NB
cell-free explants and also with respect to gene expres-
sion and cytokine release in OAB versus NB cocultures.
However, a limitation of our study is caused by the con-
trol group, which consists of trauma patients who have a
lower mean age than those individuals with OA included
into the study group. Therefore, differences in cytokine
release as we have observed between NB and OAB
might result not only from OA pathogenesis but also
from different metabolic activities due to the age of the
bone donor. In the current study, it is thus not possible
to assign these metabolic alterations specifically to OA
as age of bone donors might have also an impact.Conclusions
We observed elevated soluble factors in coculture super-
natants compared to monocultures in parallel to a meta-
bolic shift in cocultured BMSC and OA chondrocytes,
which affects synthesis of collagens and proteoglycans.
This reduced biosynthesis of structural macromolecules
alters composition of the fibrillar collagen networks of
the ECM and impairs mechanical stability and integrity
of the newly formed matrix. However, impaired produc-
tion of proteoglycans appears to be compensated during
culture time and thus not to be responsible for inferior
mechanical properties of the ECM.
We suggest that these effects are at least partly mediated
by IL-1ß, bFGF and IL-6, which are increased in coculture
supernatants while IL-8 effects are less pronounced with
respect to investigated parameters.
Our data imply that implanting BMSC or chondrocytes
into subchondral bone lesions or onto the surface of
denuded OA bone will not result in formation or regener-
ation of a well functional cartilage-like matrix. Thus before
trying to restore eroded cartilage tissue in an OA-affected
joint by a cell-based approach, release of proinflammatory
cytokines and additional soluble factors as GAGs and
growth factors from surrounding tissues has to be strictly
controlled.Additional files
Additional file 1: Figure S2. FACS analysis of BMSC surface markers
and staining of adipogenic and osteogenic differentiated BMSC. (A)
Isolated plastic adherent BMSC in passage 3 were analyzed by flow
cytometry using specific antibodies against BMSC negative markers CD
19 and CD 34 and BMSC positive markers CD 44 and CD 105 (red line).
Specificity of epitope staining was proofed using an isotype control
(black line). (B) BMSC were stained with oil red for oil drops incorporated
during adipogenic differentiation (upper row) and with alizarin red for
matrix mineralization during osteogenic differentiation (lower row).Additional file 2: Figure S1. Vitality of fibrin gel-embedded cells and
coculture setups. Vitality of (A) BMSC, (B) mixed cultures (BMSC and
chondrocytes in a ratio of 1:1) and (C) chondrocytes was determined in
monocultures (F) and co- or tricultures with OAB (FB) kept in chondrogenic
medium. Content of LDH was quantified in the supernatant of days 7, 14,
21 and 28 and compared to assay controls (high control = all cells in fibrin
gels were lysed; low control = spontaneous cell death of an equivalent
cell amount in monolayer). Due to high interexperimental variability, we
have calculated the raw data as a percentage of control per individual
experiment. Results are mean with standard variation (SD). N =4; *P <0.05,
**P <0.01, ***P <0.001.
Additional file 3: Figure S3. Quantification of gene expression in BMSC
monocultures stimulated with OA bone explants conditioned medium.
Gene expression level of (A) COL1A1, (B) COL2A1, (C) COL3A1 and (D)
COL10A1 were determined in monocultures supplemented with OAB-
conditioned medium using plasmid standard curves. BMSC monoculture
with fresh medium (F, bars with pattern) and monoculture of BMSC
supplemented with OAB conditioned chondrogenic medium (F + CM,
blank bars) were analyzed after 7 or 28 days. Due to high interexperimental
variability we have calculated the raw data as a percentage of highest cDNA
copy number per individual experiment. Solid lines indicate significant
differences between culture conditions, dotted lines indicate significant
differences between culture time points (days 7 and 28). N =4; *P <0.05,
**P <0.01, ***P <0.001.
Additional file 4: Table S1. Statistical data (P values). P values of:
(A) Cocultures vs. monocultures and normal vs. OA subchondral bone
cocultures. COL1A1, COL2A1, COL3A1 and COL10A1 gene expression
determined in ASC, BMSC, mixed cultures or chondrocytes kept as
monocultures (F) or as co- and tricultures with osteoarthritic (OA FB)
or normal subchondral bone explants (NB FB) at day 7 and day 28
(corresponding to Figure 2). (B) Cocultures vs. monocultures. Collagen
protein (day 28) and proteoglycan (day 7) quantification in cell lysates
from BMSC, mixed cultures or chondrocytes kept as monocultures (F)
or as co- and tricultures with OA subchondral bone explants (FB)
(corresponding to Figure 3).
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